Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 7/20 | 0.67 |
| ▸ | DRD3 | P35462 | 5/20 | 0.56 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.51 |
| ▸ | DRD4 | P21917 | 3/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | ACHE | P22303 | 1/20 | 0.45 |
| ▸ | RB1 | P06400 | 2/20 | 0.41 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.39 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7492298 | 0.82 | DRD2 (0.46) | DRD2DRD3GRIN2BDRD4CA1 | |
| SCHEMBL3320662 | 0.81 | DRD2 (1.00) | DRD2DRD3GRIN2BDRD4CA1 | |
| SCHEMBL29354627 | 0.81 | DRD2 (1.00) | DRD2DRD3GRIN2BDRD4CA1 | |
| SCHEMBL338733 | 0.81 | DRD2 (1.00) | DRD2DRD3GRIN2BDRD4CA1 | |
| SCHEMBL339286 | 0.81 | DRD2 (1.00) | DRD2DRD3GRIN2BDRD4CA1 | |
| SCHEMBL15474018 | 0.81 | DRD2 (1.00) | DRD2DRD3GRIN2BDRD4CA1 | |
| SCHEMBL7486376 | 0.79 | DRD2 (0.58) | DRD2DRD3DRD4 | |
| SCHEMBL7718891 | 0.76 | DRD2 (0.36) | DRD2DRD3DRD4CA1CA2 | |
| SCHEMBL11960195 | 0.75 | DRD2 (0.71) | DRD2DRD3GRIN2BDRD4RB1 | |
| SCHEMBL10043003 | 0.75 | DRD2 (0.71) | DRD2DRD3GRIN2BDRD4RB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0842161-B1 | 4,5-DIARYL OXAZOLE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO (JP) | 2002-09-18 | — | — | EP | disclosed |
| EP-1213285-A2 | 4,5-dipheny-oxazole derivatives and their use as platelet aggregation inhibitors | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-06-12 | — | — | EP | disclosed |
| US-6300344-B1 | FOR THERAPEUTIC AND/OR PROPHYLACTIC TREATMENT OF ARTERIAL OBSTRUCTION, CEREBROVASCULAR DISEASE, HEPATIC CIRRHOSIS, ARTERIOSCLEROSIS, ISCHEMIC HEART DISEASE, RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY, HYPERTENSION | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-10-09 | — | — | US | disclosed |
| US-5972965-A | USEFUL FOR INHIBITION OF PLATELET AGGREGATION, VASODILATION, ANTIHYPERTENSIVE ACTIVITY AND PROSTAGLANDIN AGONIST | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-10-26 | — | — | US | disclosed |
| EP-0842161-A1 | 4,5-DIARYL OXAZOLE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-05-20 | — | — | EP | disclosed |
| WO-1997003973-A1 | 4,5-DIARYL OXAZOLE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-02-06 | — | — | WO | disclosed |